Search articles by title, topic or section.
Khabre desk
Recent reporting, analysis and explainers from the NHS desk.
health
A BMJ editorial argues that growth in commercial testosterone prescribing could shift treatment monitoring and side-effect management to the NHS. It calls for national reporting of private prescriptions and transfers of care.
health
A Nature Medicine correspondence argues that debate over polygenic scores in England’s NHS depends partly on what prevention is meant to achieve. The authors say risk thresholds, outcome measures and comparators shape how the evidence is judged.
health
A BMJ editorial argues that major risks are often worsened when organisations fail to act on warning signs. It connects concerns about AI, vaccine safety surveillance and NHS management to weaknesses in risk escalation and accountability.
health
The Thirlwall Public Inquiry found that doctors’ concerns about Lucy Letby were dismissed at the Countess of Chester Hospital and that earlier police involvement might have saved some babies. It recommended tighter neonatal monitoring, insulin-access controls and a barring system for NHS managers dismissed for serious misconduct.
health
NHS England will make trastuzumab deruxtecan, sold as Enhertu, available to around 1,000 women with HER2-low advanced or metastatic breast cancer after their disease progresses following treatment.